On Monday, Hologic HOLX released its fiscal 2024 fourth-quarter financial report after the closing bell, with revenues slightly surpassing the consensus mark. The bottom line fell short of estimates...
QIAGEN N.V.’s QGEN third-quarter 2024 adjusted earnings per share (EPS) were 57 cents, 58 cents at the constant exchange rate (CER). The reported figure increased 14% from the 2023 comparable figure...
QIAGEN N.V. QGEN is well-poised to grow in the coming quarter, driven by its strategic alliances with researchers and pharma companies. The company’s expansive next-generation sequencing (NSG) portfolio...
/Bio-Rad%20Laboratories%20Inc_%20magnified-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Despite Bio-Rad Laboratories’ underperformance relative to the healthcare sector over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Shares of Hologic HOLX are showing impressive gains of late, trading quite near its 52-week high of $84.67. The stock closed Thursday at $80.99, just 4.3% below the highest point. In the past three months,...
Investors continue to wonder how long stocks will keep moving higher. Friday’s jobs report suggests the economy is much stronger than most people realize, which is good news for stocks.